IOL CHEMICALS & PHARM. | BIOCON | IOL CHEMICALS & PHARM./ BIOCON |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 12.4 | 19.7 | 62.8% | View Chart |
P/BV | x | 1.4 | 1.8 | 78.1% | View Chart |
Dividend Yield | % | 1.1 | 0.6 | 194.8% |
IOL CHEMICALS & PHARM. BIOCON |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
BIOCON Mar-23 |
IOL CHEMICALS & PHARM./ BIOCON |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 388 | 138.4% | |
Low | Rs | 272 | 192 | 142.1% | |
Sales per share (Unadj.) | Rs | 377.6 | 93.1 | 405.7% | |
Earnings per share (Unadj.) | Rs | 23.7 | 5.4 | 442.5% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 14.6 | 215.8% | |
Dividends per share (Unadj.) | Rs | 4.00 | 1.50 | 266.7% | |
Avg Dividend yield | % | 1.0 | 0.5 | 191.0% | |
Book value per share (Unadj.) | Rs | 256.8 | 146.5 | 175.3% | |
Shares outstanding (eoy) | m | 58.71 | 1,200.60 | 4.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 3.1 | 34.4% | |
Avg P/E ratio | x | 17.1 | 54.1 | 31.5% | |
P/CF ratio (eoy) | x | 12.8 | 19.8 | 64.7% | |
Price / Book Value ratio | x | 1.6 | 2.0 | 79.7% | |
Dividend payout | % | 16.9 | 28.0 | 60.3% | |
Avg Mkt Cap | Rs m | 23,743 | 347,814 | 6.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 21,810 | 7.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 111,742 | 19.8% | |
Other income | Rs m | 256 | 7,681 | 3.3% | |
Total revenues | Rs m | 22,427 | 119,423 | 18.8% | |
Gross profit | Rs m | 2,257 | 16,611 | 13.6% | |
Depreciation | Rs m | 462 | 11,131 | 4.1% | |
Interest | Rs m | 165 | 4,190 | 3.9% | |
Profit before tax | Rs m | 1,887 | 8,971 | 21.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 2,541 | 19.5% | |
Profit after tax | Rs m | 1,391 | 6,430 | 21.6% | |
Gross profit margin | % | 10.2 | 14.9 | 68.5% | |
Effective tax rate | % | 26.2 | 28.3 | 92.7% | |
Net profit margin | % | 6.3 | 5.8 | 109.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 123,340 | 7.8% | |
Current liabilities | Rs m | 5,025 | 85,107 | 5.9% | |
Net working cap to sales | % | 20.9 | 34.2 | 61.2% | |
Current ratio | x | 1.9 | 1.4 | 132.7% | |
Inventory Days | Days | 43 | 129 | 33.5% | |
Debtors Days | Days | 8 | 117 | 7.1% | |
Net fixed assets | Rs m | 11,017 | 394,078 | 2.8% | |
Share capital | Rs m | 587 | 6,003 | 9.8% | |
"Free" reserves | Rs m | 14,490 | 169,926 | 8.5% | |
Net worth | Rs m | 15,077 | 175,929 | 8.6% | |
Long term debt | Rs m | 0 | 152,905 | 0.0% | |
Total assets | Rs m | 20,684 | 517,418 | 4.0% | |
Interest coverage | x | 12.5 | 3.1 | 396.5% | |
Debt to equity ratio | x | 0 | 0.9 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.2 | 496.3% | |
Return on assets | % | 7.5 | 2.1 | 366.5% | |
Return on equity | % | 9.2 | 3.7 | 252.5% | |
Return on capital | % | 13.6 | 4.0 | 339.9% | |
Exports to sales | % | 26.7 | 3.1 | 862.1% | |
Imports to sales | % | 0 | 6.0 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 3,467 | 171.0% | |
Imports (cif) | Rs m | NA | 6,654 | 0.0% | |
Fx inflow | Rs m | 5,930 | 3,467 | 171.0% | |
Fx outflow | Rs m | 6,052 | 6,654 | 90.9% | |
Net fx | Rs m | -122 | -3,187 | 3.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 18,525 | 6.6% | |
From Investments | Rs m | -1,200 | -142,818 | 0.8% | |
From Financial Activity | Rs m | -41 | 130,487 | -0.0% | |
Net Cashflow | Rs m | -18 | 6,411 | -0.3% |
Indian Promoters | % | 48.2 | 40.4 | 119.4% | |
Foreign collaborators | % | 0.0 | 20.3 | - | |
Indian inst/Mut Fund | % | 2.5 | 21.1 | 12.1% | |
FIIs | % | 2.2 | 6.6 | 33.3% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 39.4 | 131.6% | |
Shareholders | 134,235 | 434,339 | 30.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: SUN PHARMA DIVIS LABORATORIES CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | Biocon | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.31% | 2.92% | 1.18% |
1-Month | -9.26% | -2.53% | -0.75% |
1-Year | 29.97% | 30.52% | 61.82% |
3-Year CAGR | -13.41% | -13.55% | 18.16% |
5-Year CAGR | 13.41% | -2.73% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the Biocon share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of Biocon the stake stands at 60.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of Biocon.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
Biocon paid Rs 1.5, and its dividend payout ratio stood at 28.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of Biocon.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.